Korro Bio, Inc. (KRRO)
11.15
-0.26
(-2.28%)
USD |
NASDAQ |
Mar 19, 10:41
Korro Bio Market Cap : 110.61M for March 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cencora, Inc. | 64.39B |
| BioCryst Pharmaceuticals, Inc. | 2.358B |
| United Therapeutics Corp. | 23.27B |
| Collegium Pharmaceutical, Inc. | 1.133B |
| ProKidney Corp. | 274.60M |
Market Cap Related Metrics
| PS Ratio | 16.38 |
| PEG Ratio | -0.0271 |
| Price to Book Value | 2.150 |
| Price | 11.15 |
| Earnings Yield | -111.9% |
| PEGY Ratio | -0.0271 |